Prostatis Group’s THOR Index Rotation ETF THIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$72.1M Sell
2,090,943
-27,916
-1% -$923K 16.8% 1
2026
Q1
$65.7M Sell
2,118,859
-256,094
-11% -$8.29M 16.82% 1
2025
Q4
$76.5M Buy
2,374,953
+135,874
+6% +$4.34M 18.27% 1
2025
Q3
$70.3M Buy
2,239,079
+1,789,556
+398% +$53.9M 17.62% 1
2025
Q2
$13.1M Buy
449,523
+421,199
+1,487% +$11.3M 3.76% 5
2025
Q1
$702K Sell
28,324
-33,612
-54% -$868K 0.22% 83
2024
Q4
$1.6M Sell
61,936
-31,197
-33% -$808K 0.47% 47
2024
Q3
$2.34M Buy
+93,133
New +$2.34M 0.77% 40

Other funds holding THIR

Prostatis Group's THIR Position: Q2 2026 in Review

Prostatis Group reduced its THOR Index Rotation ETF (THIR) stake by 1.3% in Q2 2026, selling an estimated $923K and leaving 2,090,943 shares worth $72.1M. The position accounts for 16.8% of the portfolio, ranked #1.

Prostatis Group first reported a position in THIR in Q3 2024 and has held it in 8 quarters since. The position peaked at $76.5M in Q4 2025. 22 funds tracked by Wall St. Rank hold THIR as of Q2 2026.

  • Prostatis Group held 2,090,943 shares of THOR Index Rotation ETF worth $72.1M as of Q2 2026.
  • Prostatis Group sold 27,916 THOR Index Rotation ETF shares in Q2 2026, an estimated $923K.
  • THOR Index Rotation ETF made up 16.8% of Prostatis Group's portfolio in Q2 2026, its #1 holding.
  • Prostatis Group first reported a position in THOR Index Rotation ETF in Q3 2024 and has held it in 8 quarters since.
  • Prostatis Group's THOR Index Rotation ETF position peaked at $76.5M in Q4 2025.
  • 22 funds tracked by Wall St. Rank held THOR Index Rotation ETF as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.